Table 3.
Patients at low risk in primary prevention
| Complex intervention A n = 366 | Simple intervention B n = 384 | A vs. B | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean FU | 95% CI | Mean FU | 95% CI | Difference/Odds ratio | 95% CI | p | ICC | p | |
| CVR | 2.9% | 2.7%-3.1% | 2.7% | 2.5%-2.9% | Δ = 0.2% | -0.1%-0.5% | 0.282 | 0.032 | 0.043 |
| RR systolic [mmHg] | 134.0 | 132.1-135.9 | 134.3 | 132.3-136.2 | Δ = -0.2 | -2.9-2.5 | 0.866 | 0.097 | <0.001 |
| RR diastolic [mmHg] | 80.9 | 79.9-82.0 | 80.7 | 79.7-81.8 | Δ = 0.2 | -1.3-1.7 | 0.798 | 0.063 | <0.001 |
| Control rate RR < 140/90 | 58.1% | 51.3%-64.8% | 54.0% | 47.1%-60.9% | OR = 1.19 | 0.78-1.82 | 0.411 | 0.098 | <0.001 |
| Control rate RR < 160/95 | 90.2% | 86.8%-93.6% | 90.7% | 87.4%-94.0% | OR = 0.94 | 0.55-1.62 | 0.830 | 0.051 | 0.205 |
| Cholesterol [mg/dl] | 216.6 | 213.0-220.1 | 219.3 | 215.7-222.8 | Δ = -2.7 | -7.7-2.3 | 0.294 | 0.021 | 0.103 |
| Current smoker | 16.2% | 12.5%-20.0% | 16.4% | 12.5%-20.3% | OR = 0.98 | 0.48-1.99 | 0.948 | 0.240 | <0.001 |
| ASS | 9.0% | 7.0%-10.9% | 9.2% | 7.3%-11.2% | OR = 0.89 | 0.32-2.43 | 0.815 | 0.318 | 0.001 |
| Statins | 18.1% | 14.6%-21.6% | 13.5% | 10.2%-16.7% | OR = 1.89 | 0.98-3.62 | 0.056 | 0.150 | 0.010 |
Outcomes at follow up in subpopulation at low CVR (10-year mortality < 5%) with no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.